Issue : The Pharmaceutical Journal, August 2019, Vol 303, No 7928
Sort by: Newest first Oldest first A-Z Z-A
-
We're grateful for the clarity, but the new pharmacy contract fails to fix our broken market Subscription
The new community pharmacy contractual framework offers pharmacists some hope of a future, but the flawed Category M reimbursement system — which sees only wholesalers cashing in the chips — still needs to go.
-
Tribute: William Thomas Brookes
I served with Bill on the Council of the Guild of Healthcare Pharmacists (GHP) and on Pharmaceutical Whitley Council in the 1980s where we, together with others, successfully negotiated the new flexible grading criteria for hospital pharmacists, as well as an emergency duty agreement.
-
Tribute: Olwyn Elizabeth Morris (née Robson)
It is with deep sadness that we report the passing of our dear friend Olwyn Morris (née Robson).
-
Tribute: Bill Brookes
Bill was a close friend for over 50 years and I have written this to celebrate Bill as a person. I am sure others will describe his professional achievements.
-
The new NHS Patient Safety Strategy has a big hole in it Subscription
In August 2018, I expressed my concern in Clinical Pharmacist that the NHS, described as ‘an organisation with a memory’, was losing its patient safety memory and not addressing many important risks effectively[1]. Other reports from the Care Quality Commission
-
The evolution of NHS 111 Subscription
First piloted in 2011, the NHS 111 service is constantly evolving and pharmacists are being increasingly recognised for the role they can have within it. Although models across England, Scotland and Wales share the same general objectives, they have developed separately, resulting in different versions of the service with different visions for its future.
-
Statin treatment associated with reduced risk of glaucoma Subscription
Receiving statin treatment for five years or more is associated with a 21% reduced risk of primary glaucoma, research has shown.
-
Six things to look for in a pharmacy preregistration placement Subscription
Preferencing the right training providers in Oriel will be one of the most important decisions for a future trainee to make. Here is what students should consider before making that choice.
-
SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetes Subscription
Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.
-
Sandra Gidley: 'It’s not appropriate for the RPS to take a stance on Brexit'
As former chair of the English Pharmacy Board, newly elected president Sandra Gidley says she is in a great place to engage with members and continue steering the Society’s work to raise pharmacy’s profile in the wider healthcare sector.
Show 10 per page20 per page50 per page
